ARCA biopharma, Inc. ABIO
28.80 +28.80
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2023 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 7.30M | 10.60M | 19.34M | 9.77M | 5.81M | |
| 1.01M | 4.75M | 13.83M | 4.99M | 1.83M | |
| 6.28M | 5.85M | 5.50M | 4.77M | 3.98M | |
| -7.30M | -10.60M | -19.34M | -9.77M | -5.81M | |
| -5.34M | -9.93M | -19.32M | -9.74M | -5.48M | |
| -5.34M | -9.93M | -19.32M | -9.74M | -5.48M | |
| -5.34M | -9.93M | -19.32M | -9.74M | -5.48M | |
| -5.34M | -9.93M | -19.32M | -9.74M | -5.48M | |
| -0.37 | -0.69 | -1.39 | -2.07 | -4.15 | |
| -0.37 | -0.69 | -1.39 | -2.07 | -4.15 | |
| -0.37 | -0.69 | -1.39 | -2.07 | -4.15 | |
| -5.34M | -9.93M | -19.32M | -9.74M | -5.64M | |
| -5.34M | -9.93M | -19.32M | -9.74M | -5.64M | |
| 14.42M | 14.41M | 13.90M | 4.71M | 1.32M | |
| 14.42M | 14.41M | 13.90M | 4.71M | 1.32M |